1 Korkki, S. M., Richter, F. R., Jeyarathnarajah, P. & Simons, J. S. Healthy ageing reduces the precision of episodic memory retrieval. Psychol Aging 35, 124-142, doi:10.1037/pag0000432 (2020).
2 Langnes, E. et al. Anterior and posterior hippocampus macro- and microstructure across the lifespan in relation to memory-A longitudinal study. Hippocampus 30, 678-692, doi:10.1002/hipo.23189 (2020).
3 Tromp, D., Dufour, A., Lithfous, S., Pebayle, T. & Despres, O. Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies. Ageing Res Rev 24, 232-262, doi:10.1016/j.arr.2015.08.006 (2015).
4 Petersen, R. C. Mild cognitive impairment as a diagnostic entity. J Intern Med 256, 183-194, doi:10.1111/j.1365-2796.2004.01388.x (2004).
5 Bennett, D. A. et al. Natural history of mild cognitive impairment in older persons. Neurology 59, 198-205, doi:10.1212/wnl.59.2.198 (2002).
6 Morley, J. E. Mild cognitive impairment-a treatable condition. J Am Med Dir Assoc 15, 1-5, doi:10.1016/j.jamda.2013.11.001 (2014).
7 Stefaniak, J. & O'Brien, J. Imaging of neuroinflammation in dementia: a review. J Neurol Neurosurg Psychiatry 87, 21-28, doi:10.1136/jnnp-2015-311336 (2016).
8 Chandra, A. et al. Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment. Hum Brain Mapp 40, 5424-5442, doi:10.1002/hbm.24782 (2019).
9 Bradburn, S., Murgatroyd, C. & Ray, N. Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis. Ageing Res Rev 50, 1-8, doi:10.1016/j.arr.2019.01.002 (2019).
10 Sindi, S. et al. Healthy Dietary Changes in Midlife Are Associated with Reduced Dementia Risk Later in Life. Nutrients 10, doi:10.3390/nu10111649 (2018).
11 Kivipelto, M., Mangialasche, F. & Ngandu, T. Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat Rev Neurol 14, 653-666, doi:10.1038/s41582-018-0070-3 (2018).
12 Jastreboff, A. M., Kotz, C. M., Kahan, S., Kelly, A. S. & Heymsfield, S. B. Obesity as a Disease: The Obesity Society 2018 Position Statement. Obesity (Silver Spring) 27, 7-9, doi:10.1002/oby.22378 (2019).
13 in Future Directions for the Demography of Aging: Proceedings of a Workshop (eds M. K. Majmundar & M. D. Hayward) (2018).
14 Makarewich, C. A. & Olson, E. N. Mining for Micropeptides. Trends Cell Biol 27, 685-696, doi:10.1016/j.tcb.2017.04.006 (2017).
15 Andrews, S. J. & Rothnagel, J. A. Emerging evidence for functional peptides encoded by short open reading frames. Nat Rev Genet 15, 193-204, doi:10.1038/nrg3520 (2014).
16 Saghatelian, A. & Couso, J. P. Discovery and characterization of smORF-encoded bioactive polypeptides. Nat Chem Biol 11, 909-916, doi:10.1038/nchembio.1964 (2015).
17 Kumar, K. G. et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell metabolism 8, 468-481, doi:10.1016/j.cmet.2008.10.011. PMCID: 2746325 (2008).
18 Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419, doi:10.1126/science.1260419 (2015).
19 Wang, P. et al. Mapping spatial transcriptome with light-activated proximity-dependent RNA labeling. Nat Chem Biol 15, 1110-1119, doi:10.1038/s41589-019-0368-5 (2019).
20 Butler, A. A. et al. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. The Journal of clinical endocrinology and metabolism 97, 3783-3791, doi:10.1210/jc.2012-2194. PMCID: 3462944 (2012).
21 Gao, S. et al. Regulation of substrate oxidation preferences in muscle by the peptide hormone adropin. Diabetes 63, 3242-3252, doi:10.2337/db14-0388. PMCID: 4171656 (2014).
22 Gao, S. et al. Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance. Mol Metab 4, 310-324, doi:10.1016/j.molmet.2015.01.005. PMCID:PMC4354928 (2015).
23 Gao, S. et al. The peptide hormone adropin regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity. J Biol Chem 294, 13366-13377, doi:10.1074/jbc.RA119.008967 (2019).
24 Lovren, F. et al. Adropin is a novel regulator of endothelial function. Circulation 122, S185-192, doi:10.1161/CIRCULATIONAHA.109.931782 (2010).
25 Thapa, D. et al. Adropin regulates pyruvate dehydrogenase in cardiac cells via a novel GPCR-MAPK-PDK4 signaling pathway. Redox Biol 18, 25-32, doi:10.1016/j.redox.2018.06.003 (2018).
26 Thapa, D. et al. Adropin reduces blood glucose levels in mice by limiting hepatic glucose production. Physiol Rep 7, e14043, doi:10.14814/phy2.14043 (2019).
27 Thapa, D. et al. Adropin treatment restores cardiac glucose oxidation in pre-diabetic obese mice. J Mol Cell Cardiol, doi:10.1016/j.yjmcc.2019.02.012 (2019).
28 Stein, L. M., Yosten, G. L. & Samson, W. K. Adropin acts in brain to inhibit water drinking: potential interaction with the orphan G protein-coupled receptor, GPR19. Am J Physiol Regul Integr Comp Physiol 310, R476-480, doi:10.1152/ajpregu.00511.2015 (2016).
29 Rao, A. & Herr, D. R. G protein-coupled receptor GPR19 regulates E-cadherin expression and invasion of breast cancer cells. Biochim Biophys Acta Mol Cell Res 1864, 1318-1327, doi:10.1016/j.bbamcr.2017.05.001 (2017).
30 Altamimi, T. R. et al. Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency. Metabolism 98, 37-48, doi:10.1016/j.metabol.2019.06.005 (2019).
31 Ganesh Kumar, K. et al. Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring) 20, 1394-1402, doi:10.1038/oby.2012.31 (2012).
32 Lian, A., Wu, K., Liu, T., Jiang, N. & Jiang, Q. Adropin induction of lipoprotein lipase expression in tilapia hepatocytes. J Mol Endocrinol 56, 11-22, doi:10.1530/JME-15-0207 (2016).
33 Ghoshal, S. et al. Adropin: An endocrine link between the biological clock and cholesterol homeostasis. Mol Metab 8, 51-64, doi:10.1016/j.molmet.2017.12.002 (2018).
34 Butler, A. A. et al. Low plasma adropin concentrations increase risks of weight gain and metabolic dysregulation in response to a high-sugar diet in male nonhuman primates. J Biol Chem 294, 9706-9719, doi:10.1074/jbc.RA119.007528 (2019).
35 Chen, X. et al. Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity. Redox Biol 21, 101068, doi:10.1016/j.redox.2018.101068 (2019).
36 Chen, X. et al. Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin-resistant hepatocytes. FASEB J, doi:10.1096/fj.202000115RR (2020).
37 Zhang, C., Zhang, Q., Huang, Z. & Jiang, Q. Adropin inhibited tilapia hepatic glucose output and triglyceride accumulation via AMPK activation. J Endocrinol 246, 109-122, doi:10.1530/JOE-20-0077 (2020).
38 Kwon, O. S., Andtbacka, R. H. I., Hyngstrom, J. R. & Richardson, R. S. Vasodilatory function in human skeletal muscle feed arteries with advancing age: the role of adropin. J Physiol, doi:10.1113/JP277410 (2019).
39 Wu, L., Fang, J., Yuan, X., Xiong, C. & Chen, L. Adropin reduces hypoxia/reoxygenation-induced myocardial injury via the reperfusion injury salvage kinase pathway. Exp Ther Med 18, 3307-3314, doi:10.3892/etm.2019.7937 (2019).
40 Yang, C., DeMars, K. M., Hawkins, K. E. & Candelario-Jalil, E. Adropin reduces paracellular permeability of rat brain endothelial cells exposed to ischemia-like conditions. Peptides, doi:10.1016/j.peptides.2016.03.009 (2016).
41 Wong, C. M. et al. Adropin is a brain membrane-bound protein regulating physical activity via the NB-3/Notch signaling pathway in mice. J Biol Chem 289, 25976-25986, doi:10.1074/jbc.M114.576058 (2014).
42 Fagerberg, L. et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 13, 397-406, doi:10.1074/mcp.M113.035600 (2014).
43 Mure, L. S. et al. Diurnal transcriptome atlas of a primate across major neural and peripheral tissues. Science 359, doi:10.1126/science.aao0318 (2018).
44 Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45, 580-585, doi:10.1038/ng.2653 (2013).
45 O'Dowd, B. F. et al. A novel gene codes for a putative G protein-coupled receptor with an abundant expression in brain. FEBS Lett 394, 325-329, doi:10.1016/0014-5793(96)00901-5 (1996).
46 Hoffmeister-Ullerich, S. A., Susens, U. & Schaller, H. C. The orphan G-protein-coupled receptor GPR19 is expressed predominantly in neuronal cells during mouse embryogenesis. Cell Tissue Res 318, 459-463, doi:10.1007/s00441-004-0948-9 (2004).
47 Alexander, S. P. et al. Class A Orphans (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE (5), doi:doi.org/10.2218/gtopdb/F16/2019.5. (2019).
48 Foster, S. R. et al. Discovery of Human Signaling Systems: Pairing Peptides to G Protein-Coupled Receptors. Cell 179, 895-908 e821, doi:10.1016/j.cell.2019.10.010 (2019).
49 Chatterjee, M., Schild, D. & Teunissen, C. E. Contactins in the central nervous system: role in health and disease. Neural Regen Res 14, 206-216, doi:10.4103/1673-5374.244776 (2019).
50 Yang, C., DeMars, K. M. & Candelario-Jalil, E. Age-Dependent Decrease in Adropin is Associated with Reduced Levels of Endothelial Nitric Oxide Synthase and Increased Oxidative Stress in the Rat Brain. Aging Dis 9, 322-330, doi:10.14336/AD.2017.0523 (2018).
51 Zhang, Y. et al. Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse. Neuron 89, 37-53, doi:10.1016/j.neuron.2015.11.013 (2016).
52 Banerjee, S. et al. Hepatocyte expression of the micropeptide adropin regulates the liver fasting response and is enhanced by caloric restriction. J Biol Chem, doi:10.1074/jbc.RA120.014381 (2020).
53 Lanfranco, M. F., Ng, C. A. & Rebeck, G. W. ApoE Lipidation as a Therapeutic Target in Alzheimer's Disease. Int J Mol Sci 21, doi:10.3390/ijms21176336 (2020).
54 Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C. C. & Bu, G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol 15, 501-518, doi:10.1038/s41582-019-0228-7 (2019).
55 Foster, E. M., Dangla-Valls, A., Lovestone, S., Ribe, E. M. & Buckley, N. J. Clusterin in Alzheimer's Disease: Mechanisms, Genetics, and Lessons From Other Pathologies. Front Neurosci 13, 164, doi:10.3389/fnins.2019.00164 (2019).
56 Hernandez, F., Lucas, J. J. & Avila, J. GSK3 and tau: two convergence points in Alzheimer's disease. J Alzheimers Dis 33 Suppl 1, S141-144, doi:10.3233/JAD-2012-129025 (2013).
57 Miao, L. et al. mTORC1 is necessary but mTORC2 and GSK3beta are inhibitory for AKT3-induced axon regeneration in the central nervous system. Elife 5, e14908, doi:10.7554/eLife.14908 (2016).
58 Sousa, A. M. M. et al. Molecular and cellular reorganization of neural circuits in the human lineage. Science 358, 1027-1032, doi:10.1126/science.aan3456 (2017).
59 Castanho, I. et al. Transcriptional Signatures of Tau and Amyloid Neuropathology. Cell Rep 30, 2040-2054 e2045, doi:10.1016/j.celrep.2020.01.063 (2020).
60 Miller, J. A. et al. Neuropathological and transcriptomic characteristics of the aged brain. Elife 6, doi:10.7554/eLife.31126 (2017).
61 Kukull, W. A. et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol 59, 1737-1746, doi:10.1001/archneur.59.11.1737 (2002).
62 Larson, E. B. et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 144, 73-81, doi:10.7326/0003-4819-144-2-200601170-00004 (2006).
63 Crane, P. K. et al. Glucose levels and risk of dementia. N Engl J Med 369, 540-548, doi:10.1056/NEJMoa1215740 (2013).
64 Sonnen, J. A. et al. Neuropathology in the adult changes in thought study: a review. J Alzheimers Dis 18, 703-711, doi:10.3233/JAD-2009-1180 (2009).
65 Monoranu, C. M. et al. pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium. Neuropathol Appl Neurobiol 35, 329-337, doi:10.1111/j.1365-2990.2008.01003a.x (2009).
66 Mills, J. D. et al. The alternative splicing of the apolipoprotein E gene is unperturbed in the brains of Alzheimer's disease patients. Mol Biol Rep 41, 6365-6376, doi:10.1007/s11033-014-3516-8 (2014).
67 Kwon, O. S., Andtbacka, R. H. I., Hyngstrom, J. R. & Richardson, R. S. Vasodilatory function in human skeletal muscle feed arteries with advancing age: the role of adropin. J Physiol 597, 1791-1804, doi:10.1113/JP277410 (2019).
68 Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34, 11929-11947, doi:10.1523/JNEUROSCI.1860-14.2014 (2014).
69 Clarke, L. E. et al. Normal aging induces A1-like astrocyte reactivity. Proc Natl Acad Sci U S A 115, E1896-E1905, doi:10.1073/pnas.1800165115 (2018).
70 Flurkey, K., Currer, J. M. & Harrison, D. E. in The Mouse in Biomedical Research 2nd Edition (eds J.G. Fox et al.) (Elsevier, 2007).
71 Arch, J. R., Hislop, D., Wang, S. J. & Speakman, J. R. Some mathematical and technical issues in the measurement and interpretation of open-circuit indirect calorimetry in small animals. Int J Obes (Lond) 30, 1322-1331, doi:10.1038/sj.ijo.0803280 (2006).
72 Magistretti, P. J. & Allaman, I. A cellular perspective on brain energy metabolism and functional imaging. Neuron 86, 883-901, doi:10.1016/j.neuron.2015.03.035 (2015).
73 Ouimet, B. et al. Motor learning deficits and striatal GSK-3 hyperactivity in Akt3 knockout mice. Behav Neurosci 133, 135-143, doi:10.1037/bne0000292 (2019).
74 Gomez-Pinilla, F. Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 9, 568-578, doi:10.1038/nrn2421 (2008).
75 St-Onge, M. P. et al. Fasting plasma adropin concentrations correlate with fat consumption in human females. Obesity (Silver Spring) 22, 1056-1063, doi:10.1002/oby.20631. PMCID: 3968187 (2014).
76 Stevens, J. R. et al. Inverse association between carbohydrate consumption and plasma adropin concentrations in humans. Obesity (Silver Spring) 24, 1731-1740, doi:10.1002/oby.21557. PMCID:PMC5184848 (2016).
77 van der Klaauw, A. A. et al. Divergent effects of central melanocortin signalling on fat and sucrose preference in humans. Nat Commun 7, 13055, doi:10.1038/ncomms13055 (2016).
78 Hill, C. M. et al. FGF21 and the Physiological Regulation of Macronutrient Preference. Endocrinology 161, doi:10.1210/endocr/bqaa019 (2020).
79 Fouda, A. Y., Fagan, S. C. & Ergul, A. Brain Vasculature and Cognition. Arterioscler Thromb Vasc Biol 39, 593-602, doi:10.1161/ATVBAHA.118.311906 (2019).
80 Abondio, P. et al. The Genetic Variability of APOE in Different Human Populations and Its Implications for Longevity. Genes (Basel) 10, doi:10.3390/genes10030222 (2019).
81 Mei, H. et al. Expression array annotation using the BioMediator biological data integration system and the BioConductor analytic platform. AMIA Annu Symp Proc, 445-449 (2003).
82 Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5, R80, doi:10.1186/gb-2004-5-10-r80 (2004).
83 Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102, 15545-15550, doi:0506580102 [pii]
10.1073/pnas.0506580102 (2005).
84 Subramanian, A., Kuehn, H., Gould, J., Tamayo, P. & Mesirov, J. P. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 23, 3251-3253, doi:btm369 [pii]
10.1093/bioinformatics/btm369 (2007).
85 Hammond, R. S., Tull., L. E. & Stackman, R. W. On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiol Learn Mem 82, 26-34 (2004).
86 Pedros, I. et al. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease. Biochim Biophys Acta 1842, 1556-1566, doi:10.1016/j.bbadis.2014.05.025 (2014).
87 Getz, A. M., Xu, F., Visser, F., Persson, R. & Syed, N. I. Tumor suppressor menin is required for subunit-specific nAChR alpha5 transcription and nAChR-dependent presynaptic facilitation in cultured mouse hippocampal neurons. Sci Rep 7, 1768, doi:10.1038/s41598-017-01825-x (2017).
88 Mersman, B., Zaidi, W., Syed, N. I. & Xu, F. Taurine Promotes Neurite Outgrowth and Synapse Development of Both Vertebrate and Invertebrate Central Neurons. Front Synaptic Neurosci 12, 29, doi:10.3389/fnsyn.2020.00029 (2020).